Kingma Paul S, Whitsett Jeffrey A
Division of Neonatology, Perinatal, and Pulmonary Biology, Cincinnati Children's Hospital Medical Center, 3333 Burnet Ave, Cincinnati, OH 45229-3039, USA.
Curr Opin Pharmacol. 2006 Jun;6(3):277-83. doi: 10.1016/j.coph.2006.02.003. Epub 2006 Mar 30.
The lung is repeatedly exposed to inhaled particles and pathogens that are cleared by the actions of a multi-component innate host defense system. The pulmonary collectins--surfactant proteins A (SP-A) and D (SP-D)--play important roles in innate host defense by binding and clearing invading microbes from the lung. SP-A and SP-D also influence surfactant homeostasis, contributing to the physical structures of lipids in the alveoli and to the regulation of surfactant function and metabolism. In addition to binding and opsonizing infectious pathogens, SP-A and SP-D bind to the surfaces of host defense cells, promoting or inhibiting immune cell activity through multiple cellular pathways. As a consequence of their physiologic functions, SP-A- and SP-D-dependent pathways are targets for clinical therapies designed to limit the proliferation of microoorgansims and to ameliorate inflammation following pulmonary infection.
肺部反复接触吸入的颗粒和病原体,这些物质通过多组分先天性宿主防御系统的作用被清除。肺部凝集素——表面活性蛋白A(SP-A)和D(SP-D)——通过结合并清除肺部入侵的微生物,在先天性宿主防御中发挥重要作用。SP-A和SP-D还影响表面活性剂的稳态,有助于肺泡中脂质的物理结构以及表面活性剂功能和代谢的调节。除了结合并调理感染性病原体外,SP-A和SP-D还与宿主防御细胞表面结合,通过多种细胞途径促进或抑制免疫细胞活性。由于它们的生理功能,依赖SP-A和SP-D的途径成为旨在限制微生物增殖和减轻肺部感染后炎症的临床治疗靶点。